We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we ...

(Reuters) -Viatris said on Monday it would pay up to $335 million over nine years as part of a nationwide settlement to ...

Viatris reached a $335 million settlement framework to resolve opioid lawsuits, addressing over 1,000 U.S. and Canadian legal ...

The company was accused of marketing the drugs as “less prone to abuse” even though it knew the opposite was true, especially ...

New York, New York-- (Newsfile Corp. - April 16, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Viatris Inc. (NASDAQ: VTRS) and certain ...

Viatris has accrued about $270 million for the settlement, it said in its annual report filed in February. Its payment depends on its level of participation in the settlement. If it pays the highest ...

Learn more about whether Ligand Pharmaceuticals Incorporated or Viatris Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Viatris Inc. (Nasdaq: VTRS) (the "Company") today announced it has reached a nationwide settlement framework to resolve opioid-related claims by states, local governments, and Tribes against the ...

In part, the press release announced that following an "inspection of Viatris' oral finished dose manufacturing facility in ...

A New York City federal court has dismissed a proposed class-action lawsuit against Bristol Myers Squibb that accused the ...

Learn more about whether Organon & Co. or Viatris Inc. is a better investment based on AAII's A+ Investor grades, which ...

Viatris to Pay up to $335 Million to Resolve ... state and local opioid initiatives as part of the settlement. "When drug companies put profits over people, innocent patients can get sucked ...